BridgeBio Pharma, Inc.

    Jurisdiction
    United States
    LEI
    54930028YG89VTY2J114
    ISIN
    US10806X1028 (BBIO)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    49 / 100
    Even with peer group:
    49 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    3 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. Read full profile

    Fundamentals

    Net revenue
    €201.14M
    Gross margin
    96.8%
    EBIT
    -€559.21M
    EBIT margin
    -278.0%
    Net income
    -€662.24M
    Net margin
    -329.3%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €688.50M +242.3% -€331.17M -50.0%
    €1.13B +63.5% -€10.26M -96.9%
    €1.81B +60.6% €534.84M -5,312.4%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Trimarchi Thomas President and CFO -42K $49.48 -$2.09M
    Kumar Neil Chief Executive Officer -26K $48.82 -$1.28M
    Trimarchi Thomas President and CFO -17K $50.23 -$871.64K
    HOMCY CHARLES J N/A -300K $46.37 -$13.91M
    Kumar Neil Chief Executive Officer -80K $45.84 -$3.67M

    Congress transactions

    Name Transaction date Value
    Gilbert Cisneros September 12, 2025 $1.00K–$15.00K

    Investor transactions

    Name Shares Value Last change Change type
    Andreas Halvorsen 22M $762.45M -3.1M Sell

    Earnings Calls

    Add to watchlist

    Notifications